TABLE 5.

Effect of treatments on liver function parameters at the end of three months

Parameter	Atorvastatin* (n=25)	Atorvastatin + fenofibrate† (n=21)	Simvastatin‡ (n=23)	Simvastatin + fenofibrate§ (n=22)
Total bilirubin, μmol/L	11.97±4.27	11.45±3.07	12.14±4.79	12.14±4.79
SGPT, U/L	28.16±10.9	29.62±7.19	31.67±7.99	31.48±1.72
SGOT, U/L	24.46±7.1	29.14±6.59	27.62±7.28	27.55±1.56
Alk phos, U/L	94.04±23.05	69.00±16.48	74.51±26.25	73.80±5.42

^*Data expressed as mean ± SD. Degrees of freedom = 24,

^†20,

^‡22,

^§21. Alk phos Alkaline phosphatase; SGPT serum glutamicpyruvic transaminase; SGOT serum glutamicoxaloacetic transaminase